Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial.
Dale BixbyRichard NoppeneyTara L LinJorge E CortesJürgen KrauterKaren YeeBruno C MedeirosAlwin KrämerSarit AssoulineWalter FiedlerNatalie DimierBrian P SimmonsTodd RiehlDawn ColburnPublished in: British journal of haematology (2018)
Keyphrases
- basal cell carcinoma
- acute myeloid leukemia
- liver failure
- acute lymphoblastic leukemia
- respiratory failure
- study protocol
- phase iii
- multiple myeloma
- diffuse large b cell lymphoma
- hodgkin lymphoma
- bone marrow
- dendritic cells
- clinical trial
- phase ii
- drug induced
- aortic dissection
- randomized controlled trial
- hepatitis b virus
- open label
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome